Neuralink: ALS patient controls AI with brain signals

Neuralink demonstrated new capabilities of its brain implant: a clinical trial participant with amyotrophic lateral sclerosis (ALS) can now communicate and initiate phone calls using signals sent directly from the brain, integrated with artificial intelligence. This represents a significant advance over the device's previous capabilities.